Patent 11993804 was granted and assigned to Roche Molecular Systems on May, 2024 by the United States Patent and Trademark Office.
The present invention relates to the sample preparation of nucleic acids for diagnostic purposes. More precisely, the invention provides a process for simultaneously isolating at least a first and a second target nucleic acid from a plurality of different types of fluid samples and optionally amplifying said isolated nucleic acids in a simultaneous manner.